Insulin Pump Market and Forecast - Worldwide Analysis
Insulin Pumps are gaining strong acceptance in the market as insulin delivery systems especially for type 1 diabetes patients.
Online, February 3, 2014 (Newswire.com) - Insulin Pumps are gaining strong acceptance in the market as insulin delivery systems especially for type 1 diabetes patients. Insulin pumps are gaining a lot of attraction in United States and European countries. But due to high costs of insulin pumps it has still not able to penetrate successfully in emerging markets. If insulin pump cost declines then its market is expected to grow immensely. Number of insulin pump users is expected to grow with single digit CAGR for the period of 2013 to 2018.
For the year 2013 United States is having the highest market share in insulin pump market worldwide. In terms of companies share Medtronic controls a major portion of insulin pump market globally. Insulin pump market is more than 4 Billion for the year 2013. Reimbursement plays an important factor for the growth of insulin pump in any country.
Renub Research report titled "Insulin Pump Market & Forecast - Worldwide Analysis" provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 215 page report with 174 Figures and 3 Table provides a complete analysis of top 16 Countries Insulin Market and top 4 Insulin Pump Manufacturers. All the 16 countries in the report have been studied from 6 viewpoints.
1. Overall Diabetes Population (2007 - 2018)
2. Type 1 Diabetes Population (2007 - 2018)
3. Type 2 Diabetes Population (2007 - 2018)
4. Insulin Pump Users (2007 - 2018)
5. Insulin Pump Market (2007 - 2018)
6. Reimbursement Policies of all the 16 Countries
All the 16 Countries studied in the report are as follows
1. United States
2. Germany
3. Sweden
4. Switzerland
5. United Kingdom
6. Spain
7. Italy
8. Netherlands
9. Norway
10. Australia
11. France
12. Canada
13. Denmark
14. Finland
15. Israel
16. Japan
Top 4 Companies studied in the report are as follows
1. Insulet Corporation
2. Roche
3. Medtronic
4. Animas Corporation (Acquired by Johnson & Johnson)
Contact Us
Andy Hill
Sr. Manager - Publisher Relation
Sales & Marketing Div.
Renub Research
Email: info@renub.com
Phone: +1-678-302-0700 (USA) , +91-120-4219-822, +91-120-254-5750 (India)
Web: http://www.renub.com/